OTCMKTS:GRRMF - Gerresheimer Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $112.00
  • Forecasted Upside: 8.44 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$103.29
+0.30 (1.20%)

This chart shows the closing price for GRRMF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Gerresheimer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GRRMF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GRRMF

Analyst Price Target is $112.00
▲ +8.44% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Gerresheimer in the last 3 months. The average price target is $112.00, with a high forecast of $112.00 and a low forecast of $112.00. The average price target represents a 8.44% upside from the last price of $103.29.

This chart shows the closing price for GRRMF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 contributing investment analysts is to buy stock in Gerresheimer. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/27/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/13/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/13/2021JPMorgan Chase & Co.Reiterated RatingNeutral
10/13/2021Credit Suisse GroupReiterated RatingOutperform
9/17/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$112.00
9/17/2021JPMorgan Chase & Co.Reiterated RatingNeutral
1/29/2021DZ BankReiterated RatingBuy
1/22/2021Pareto SecuritiesDowngradeBuy ➝ Hold
10/19/2020DZ BankReiterated RatingSell
7/29/2020Berenberg BankReiterated RatingBuy
1/2/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
(Data available from 10/26/2016 forward)

News Sentiment Rating

0.73 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/28/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/28/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/26/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/26/2021

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

Gerresheimer logo
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Read More

Today's Range

Now: $103.29
Low: $103.29
High: $103.29

50 Day Range

MA: $103.26
Low: $103.15
High: $103.29

52 Week Range

Now: $103.29
Low: $103.15
High: $111.13

Volume

N/A

Average Volume

520 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Gerresheimer?

The following Wall Street sell-side analysts have issued research reports on Gerresheimer in the last year: Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, DZ Bank AG, JPMorgan Chase & Co., and Pareto Securities.
View the latest analyst ratings for GRRMF.

What is the current price target for Gerresheimer?

1 Wall Street analysts have set twelve-month price targets for Gerresheimer in the last year. Their average twelve-month price target is $112.00, suggesting a possible upside of 8.4%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting GRRMF will reach $112.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $112.00 for Gerresheimer in the next year.
View the latest price targets for GRRMF.

What is the current consensus analyst rating for Gerresheimer?

Gerresheimer currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GRRMF will outperform the market and that investors should add to their positions of Gerresheimer.
View the latest ratings for GRRMF.

What other companies compete with Gerresheimer?

How do I contact Gerresheimer's investor relations team?

Gerresheimer's physical mailing address is Klaus-Bungert-Strasse 4, Dusseldorf, Nordrhein-Westfalen 40468. The company's listed phone number is 49 211 6181 00. The official website for Gerresheimer is www.gerresheimer.com.